Five Prime Therapeutics, Inc. Receivables, Net, Current
Five Prime Therapeutics, Inc. had Receivables, Net, Current of $85.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:ReceivablesNetCurrent · last filed 2021-03-22
- 2020-12-31: Receivables, Net, Current $85.00K.
- 2020-09-30: Receivables, Net, Current $1.48M.
- 2020-06-30: Receivables, Net, Current $2.21M.
- 2020-03-31: Receivables, Net, Current $2.17M.
| Period end | Receivables, Net, Current |
|---|---|
| 2020-12-31 | $85.00K 10-K · filed 2021-03-22 |
| 2020-09-30 | $1.48M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $2.21M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.17M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $4.10M 10-K · filed 2021-03-22 |
| 2019-09-30 | $3.66M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $2.60M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $3.36M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $5.10M 10-K · filed 2020-02-27 |
| 2018-09-30 | $5.01M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $2.71M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $4.27M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $13.13M 10-K · filed 2019-02-26 |
| 2017-09-30 | $4.36M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $3.83M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $5.91M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $3.96M 10-K · filed 2018-02-27 |
| 2016-09-30 | $2.31M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $3.40M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $1.76M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $4.05M 10-K · filed 2017-02-24 |
| 2015-09-30 | $1.67M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $718.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $133.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $410.00K 10-K · filed 2016-03-11 |
| 2014-09-30 | $91.00K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $177.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | $20.12M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $296.00K 10-K · filed 2015-03-18 |
| 2013-09-30 | $383.00K 10-Q · filed 2013-11-13 |
| 2012-12-31 | $397.00K 10-K · filed 2014-03-26 |